ABRAXIS PHARMACEUTICAL PRODUCTS Trademark

Trademark Overview


On Wednesday, April 19, 2006, a trademark application was filed for ABRAXIS PHARMACEUTICAL PRODUCTS with the United States Patent and Trademark Office. The USPTO has given the ABRAXIS PHARMACEUTICAL PRODUCTS trademark a serial number of 78865063. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 11, 2018. This trademark is owned by Abraxis BioScience, Inc.. The ABRAXIS PHARMACEUTICAL PRODUCTS trademark is filed in the Pharmaceutical Products, Advertising and Business and Retail Services categories with the following description:

Pharmaceuticals, namely alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace elements in the nature of mineral supplements for human consumption, vitamins, micronutrients, namely nutritional supplements, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; pharmaceuticals for treatment of cancer; pharmaceuticals to treat vascular diseases; drug delivery systems composed of nanoparticles sold as an integral component of drugs; injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases in the form of prefilled IV bags as a unit, sold separately or with devices for intravenous administration, namel...

distributorship and retail ordering services featuring pharmaceuticals, namely alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace elements, vitamins, micronutrients, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; distributorship and retail ordering services featuring pharmaceuticals for the treatment of cancer, pharmaceuticals to treat vascular diseases, drug delivery systems composed of nanoparticles sold as an integral component of drugs; distributorship and retail ordering services featuring IV bags for presentation with injectable drugs or therapeutic solutions and devices for intravenous administration of pharmaceut...
abraxis pharmaceutical products

General Information


Serial Number78865063
Word MarkABRAXIS PHARMACEUTICAL PRODUCTS
Filing DateWednesday, April 19, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 11, 2018
Registration Number3309668
Registration DateTuesday, October 9, 2007
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 14, 2006

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICAL PRODUCTS"
Description of MarkThe mark consists in part of a stylized letter "A".
Goods and ServicesPharmaceuticals, namely alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace elements in the nature of mineral supplements for human consumption, vitamins, micronutrients, namely nutritional supplements, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; pharmaceuticals for treatment of cancer; pharmaceuticals to treat vascular diseases; drug delivery systems composed of nanoparticles sold as an integral component of drugs; injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases in the form of prefilled IV bags as a unit, sold separately or with devices for intravenous administration, namely transfer pins, vials, needles, adaptors and tamper resistant seals, sold as a kit
Goods and Servicesdistributorship and retail ordering services featuring pharmaceuticals, namely alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, antihistamines, anti-infectives, anti-inflammatory agents, anticonvulsants, antidotes, antiemetics, antipsychotics, anxiolytics, blood modifiers, bronchodialators, cardiovasculars, diuretics, hormones, diluents, electrolytes, trace elements, vitamins, micronutrients, oncolytics, immunosuppressive agents, transplantation agents, imaging agents, vascular targeting agents, and sensitizing agents for chemotherapy-resistant tumors; distributorship and retail ordering services featuring pharmaceuticals for the treatment of cancer, pharmaceuticals to treat vascular diseases, drug delivery systems composed of nanoparticles sold as an integral component of drugs; distributorship and retail ordering services featuring IV bags for presentation with injectable drugs or therapeutic solutions and devices for intravenous administration of pharmaceuticals, namely transfer pins, vials, needles, pumping chamber sets, lubricants, adaptors and tamper resistant seals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 11, 2018
Primary Code005
First Use Anywhere DateMonday, May 1, 2006
First Use In Commerce DateMonday, May 1, 2006

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 11, 2018
Primary Code035
First Use Anywhere DateMonday, May 1, 2006
First Use In Commerce DateMonday, May 1, 2006

Trademark Owner History


Party NameABRAXIS BIOSCIENCE, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressSummit, NJ 07901

Party NameAbraxis BioScience, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90025

Party NameAbraxis BioScience, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90025

Party NameAbraxis BioScience, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90049

Trademark Events


Event DateEvent Description
Friday, May 11, 2018CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Sunday, October 9, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Monday, January 25, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 25, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 27, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 31, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, October 31, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, October 31, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, October 10, 2012TEAS SECTION 8 & 15 RECEIVED
Friday, October 15, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 15, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 5, 2007AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, October 9, 2007REGISTERED-PRINCIPAL REGISTER
Thursday, September 6, 2007LAW OFFICE REGISTRATION REVIEW COMPLETED
Thursday, September 6, 2007ASSIGNED TO LIE
Sunday, July 29, 2007ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, July 2, 2007STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 3, 2007USE AMENDMENT FILED
Monday, May 7, 2007APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, May 7, 2007TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 3, 2007TEAS STATEMENT OF USE RECEIVED
Tuesday, February 6, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 14, 2006PUBLISHED FOR OPPOSITION
Wednesday, October 25, 2006NOTICE OF PUBLICATION
Tuesday, September 26, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, September 18, 2006ASSIGNED TO LIE
Monday, September 11, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, September 11, 2006EXAMINER'S AMENDMENT ENTERED
Monday, September 11, 2006EXAMINERS AMENDMENT E-MAILED
Monday, September 11, 2006EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 23, 2006PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, August 21, 2006WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, July 25, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, July 25, 2006ASSIGNED TO LIE
Tuesday, July 11, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 20, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, July 1, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 1, 2006EXAMINER'S AMENDMENT ENTERED
Saturday, July 1, 2006EXAMINERS AMENDMENT E-MAILED
Saturday, July 1, 2006EXAMINERS AMENDMENT -WRITTEN
Saturday, July 1, 2006AMENDMENT FROM APPLICANT ENTERED
Friday, June 23, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 20, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 20, 2006COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Tuesday, June 20, 2006ASSIGNED TO LIE
Monday, June 19, 2006EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, June 19, 2006EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Tuesday, June 13, 2006ASSIGNED TO EXAMINER
Thursday, April 27, 2006NOTICE OF DESIGN SEARCH CODE MAILED
Wednesday, April 26, 2006NEW APPLICATION ENTERED IN TRAM